Pesticide Exposure Found in Early Study to Possibly Trigger ALS
Persistent environmental pollutants like pesticides are associated with amyotrophic lateral sclerosis (ALS) and may represent modifiable ALS disease risk factors, according to…
Articles by Margarida Azevedo, MSc
ALS Researcher at Kings College London Chosen to Receive $50,000 Sheila Essey Award
Ammar Al-Chalabi, a professor of Neurology and Complex Disease Genetics at King’s College London, was presented with the  Sheila Essey…
Biogen and Cytokinetics Present Updates on 2 New Clinical Trials into ALS
During the Drug Company Working Group session at the recent American Academy of Neurology annual meeting in Vancouver, Canada, a top researcher from Cytokinetics…
ALS Technology: Organizations Launch Challenge
The ALS Association and Prize4Life have launched a joint initiative worth $400,000, to award innovation in helping improve the…
ALS Association and Cytokinetics Join to Kick Off ‘ALS Awareness Month’
May marks ALS Awareness Month, a grassroots campaign led by the ALS Association to improve understanding of, and raise research…
Neuroscientist Receives $25,000 Grant to Develop Way of Helping Advanced ALS Patients to Speak Again
The American Speech-Language-Hearing Foundation has awarded a $25,000 New Century Scholars Research Grant to neuroscientist Jonathan Brumberg to develop a brain-computer interface…
New ALS Mouse Model Reported to Accurately Mimic Disease Pathology
University of Florida Health researchers have developed a mouse model of the most common genetic mutation that causes amyotrophic lateral…
Clinical Data of Promising ALS Drug Edaravone Presented at AAN Annual Meeting
Results from the Phase 3 trial of edaravone (MCI-186) in amyotrophic lateral sclerosis (ALS) were presented by Mitsubishi Tanabe Pharma Corporation at the 68th Annual…
2 Young ALS Researchers Honored with Training and Development Awards at 2016 AAN Meeting
The ALS Association and the American Academy of Neurology (AAN) announced the 2016 winners of its Clinical Research Training Fellowship and…
ALS Association Awards Lauren Sciences a 2nd Grant to Further Develop LAUR-301, a V-Smart Nanomedicine Platform
Lauren Sciences, LLC, which specializes in medicines for neurodegenerative disorders using its V-Smart drug delivery platform, announced that it has received a…